Results

Total Results: 1,886 records

Showing results for "test".
Users also searched for: colon

1821. Future Research Needs for Treatment of Obstructive Sleep Apnea (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
      February 01, 2012 - FRN topic, we performed sample size calculations using standard formulae for a two-sided chi- squared test … As such, the process was to a large extent a test of the success of the specific protocol we envisaged … between MAD and CPAP to conduct a power calculation using standard formulae for a two-sided equivalence test … We conducted a power calculation using standard formulae for a two- sided equivalence test for mean difference

1822. Disposition of Comments for CER 201 Effectiveness of Indoor Allergen Reduction in the Management of Asthma (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-asthma-disposition-comments.pdf
      February 15, 2018 - regarding whether individuals had allergic asthma or asthma with allergic sensitization based on a skin test

1823. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
      November 01, 2010 - • We added evaluation of screening test properties to the project scope, specifically regarding

1824. S143 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
      October 01, 2007 - and those eligible for statin initiation (based on having a physician visit within 6 months of an LDL test … measures (LDL, HDL, and TG) were assumed to be valid for up to 6 months from the date of the laboratory test

1825. chronic-fatigue-protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-fatigue_research-protocol.pdf
      May 01, 2014 - concordance, any potential harm from diagnosis (such as psychological harms, labeling, risk from diagnostic test … by the Agency for Healthcare Research and Quality14 and the chapter Options for Summarizing Medical Test … Options for Summarizing Medical Test Performance in the Absence of a "Gold Standard".

1826. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
      January 01, 2015 - We will use standardized forms from the previous reviews as templates for data extraction and pilot test … outcome we consider appropriate for quantitative pooling will be tested using a standard chi-squared test … ) Visually assessing the symmetry of funnel plots b) Using the Begg and Mazumdar33 and the Egger34 test … Operating characteristics of a rank correlation test for publication bias. … Bias in meta-analysis detected by a simple, graphical test.

1827. Outcome Measure Framework Design Document (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
      January 01, 2014 - to serve as a conceptual model for development of standard outcome measures and to design and pilot test … depending on the purpose of the study and may include events (e.g., death, hospitalization), laboratory test … example, at the most basic level, a patient outcome measure collected in a registry may be a laboratory test

1828. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
      August 19, 2011 - input from Key Informants during the Topic Refinement phase, this review will not examine diagnostic test … how frequently the decision about the need for reintervention planned before IVDx changed after the test … We will test the extraction form on several studies and revise the form as necessary before full data

1829. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/field-triage-glascow_research-protocol.pdf
      February 25, 2016 - measures of discrimination (e.g., the c-index), measures of calibration (e.g., the Hosmer- Lemeshow test … The Glasgow Coma Scale at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844-54. … Chapter 8: meta-analysis of test performance when there is a "gold standard". … Empirical evidence of the importance of comparative studies of diagnostic test accuracy.

1830. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
      October 12, 2016 - Funnel plots and egger’s test should be conducted and presented for all outcomes. … (1) presenting a test for subgroup differences for DHA-only vs DHA+EPA. … *Bayley Scales of Infant Development (BSID, BSID-II, BSID-III) *Fagan Test of Infant Intelligence * … We did not pool studies that used different versions of the test. … I would have preferred that the actual cognitive or developmental test administered to an infant or

1831. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
      March 01, 2011 - entering “=tinv (p,df)”, where p is the reported p-value and df is the degree of freedom for the t-test … If the sample size is small and the study obtained the p-value using a two-sample t-test, then the … Kerwin 2008 Total (95% CI) Heterogeneity: Tau² = 0.00; Chi² = 2.28, df = 8 (P = 0.97); I² = 0% Test … Kerwin 2008 Total (95% CI) Heterogeneity: Tau² = 0.00; Chi² = 6.68, df = 10 (P = 0.76); I² = 0% Test … Kerwin 2008 Total (95% CI) Heterogeneity: Tau² = 0.00; Chi² = 7.94, df = 10 (P = 0.63); I² = 0% Test

1832. Breast-Cancer-Imaging Technical-Brief (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
      October 01, 2014 - A potential disadvantage of MRI use is that the test may be difficult for claustrophobic patients to … However, the modality does have potential disadvantages, including the relatively high cost of the test … Such a tool (e.g., a blood test) would ideally be 22 … May have a greater fear of lawsuits if they fail to order a test. … • Patients would prefer blood test over imaging if it were accurate.

1833. S96 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
      October 01, 2007 - ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*† Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…

1834. THIS IS OUR TEACHER! (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
      April 01, 2006 - Newer is always better Doctors adopt medical advances only on the basis of good science Medical test

1835. Grading_didactic_faculty_approved (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/grading.ppt
      January 01, 2010 - applicable (single study cannot be assessed) Meta-analysis: Use appropriate tests, such as Cochran’s Q test … evaluate consistency by using statistical tests and measures of heterogeneity, such as Cochran’s Q test … Intermediate or surrogate outcomes instead of health or patient-centered outcomes Example: laboratory test … ultimate outcomes, or between use of the service and the intermediate or proxy measures such as laboratory test

1836. Grading_didactic_faculty_approved (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/grading.ppt
      January 01, 2013 - applicable (single study cannot be assessed) Meta-analysis: Use appropriate tests, such as Cochran’s Q test … evaluate consistency by using statistical tests and measures of heterogeneity, such as Cochran’s Q test … Intermediate or surrogate outcomes instead of health or patient-centered outcomes Example: laboratory test … ultimate outcomes, or between use of the service and the intermediate or proxy measures such as laboratory test

1837. The Effectiveness of Indoor Allergen Reduction and the Role of Bronchial Thermoplasty in the Management of Asthma (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nonpharmacologic-treatment_research-protocol.pdf
      October 04, 2016 - excluding thermoplasty • Outcomes, all KQs o Asthma control § Composite measures* r Asthma Control Test … below in separate categories pertaining to publication type, study design, patient characteristics, test … Methods guide for medical test reviews [AHRQ Publication No. 12-EHC017]. … Also available: http://effectivehealthcare.ahrq.gov/ehc/products/246/558/Methods-Guide-for- Medical-Test-Reviews_Full-Guide

1838. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
      June 01, 2014 - surgical procedures for repairing congenital abnormalities of the heart and diaphragm, one diagnostic test

1839. #14 SUBSTANCE ABUSE (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
      June 01, 2013 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.…

1840. Disposition of Comments Report for Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
      February 26, 2013 - myocardial infarction related to a functionally non-significant stenosis (as evidenced by a negative FFR test … Commentator & Affiliation Section Comment Response and PCI was deferred based on a negative FFR test